As proof that articles aren’t necessarily written without bias, the author of this letter to the editor calls attention to the problems in the Feb. 23 article “Study casts doubt on arthritis aid” detailing the results from a study recently published in the New England Journal of Medicine comparing glucosamine and chondroitin to the prescription drug Celebrex. The Journal article creates a false bias towards Celebrex, which the numbers don’t support, calling into question the objectivity of the study. The author of the letter deftly defends glucosamine and chondroitin citing both the extremely positive results of the study and the lack of side effects of these nutritonal supplements. Read the full article.